In addition to this, a paracrine mechanism driven by EGFRvIII promotes tumor proliferation of EGFR-expressing human glioma cells and stem-like cells (GSCs) and thereby increases tumor heterogeneity and invasiveness [33]. Here, EGFR is linked to central nervous system cancer.